Apollomics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Apollomics generated cash of -$43,209,000, which is less than the previous year. Cash used in financing activities reached the amount of $21,225,000 last year. Net change in cash is therefore -$619,000.
Cash Flow
| 2019 | -21.94M | -29.86M | 9.51M |
|---|---|---|---|
| 2022 | -42.82M | 29.05M | -294K |
| 2023 | -43.20M | 21.36M | 21.22M |
APLMW Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 32.67M | 46.74M | 80.78M |
Operating activities | |||
Net income | -172.59M | -240.81M | -45.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 669K | 775K | 369K |
Stock-based compensation expense | 12.68M | 3.58M | 0 |
| Deferred income tax benefit | 12.68M | 3.58M | 0 |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 |
Cash generated by operating activities | -43.20M | -42.82M | -21.94M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | -89.4M |
Investments In Property Plant And Equipment | -6K | -367K | -857K |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | 21.36M | 29.05M | -29.86M |
Financing activities | |||
Common Stock Issued | 17.55M | 392K | 9.82M |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 24.04M | -593K | 0 |
Cash used in financing activities | 21.22M | -294K | 9.51M |
Net Change In Cash | -619K | -14.06M | -42.29M |
Cash at end of period | 32.05M | 32.67M | 38.48M |
| Data source | Data source |